Literature DB >> 18579858

DNA-binding ability of NF-kappaB is affected differently by ERalpha and ERbeta and its activation results in inhibition of estrogen responsiveness.

Ozlem Guzeloglu-Kayisli1, Gulden Halis, Sarper Taskiran, Umit A Kayisli, Aydin Arici.   

Abstract

Estrogenic effects involve interactions between estrogen receptors (ERs), response elements, and nuclear proteins. It is hypothesized that interaction between ER and NF-kappa B may affect the regulation of responsive genes. Electrophoretic mobility shift assay (EMSA) was performed to assess if the interaction of ERs and NF- kappaB affect their respective DNA-binding activities, and alkaline phosphatase assay was done to evaluate estrogenic activity. EMSA revealed that ERs inhibit DNA-binding of p50 and p65, whereas p50 did not impair ER alpha binding. Stimulation with estradiol inhibited DNA binding of NF-kappaB in ERalpha-transfected endometrial stromal cells (ESCs). Moreover, activation of NF-kappaB significantly decreased estrogen responsiveness of Ishikawa cells and ERalpha-transfected ESC. Our results suggest that ERs downregulate NF-kappaB-dependent gene activation by directly preventing DNA binding. However, NF-kappaB-mediated inhibition of ER-dependent gene activation may be carried out indirectly rather than through a direct inhibition of ER-DNA binding. These findings offer new insight into the specific role of ERalpha and could eventually help in developing therapeutics for endometriosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579858     DOI: 10.1177/1933719108317583

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  9 in total

1.  Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.

Authors:  Madhumita Pradhan; Leslie A Bembinster; Sarah C Baumgarten; Jonna Frasor
Journal:  J Biol Chem       Date:  2010-08-12       Impact factor: 5.157

2.  Prenatal exposure of mice to diethylstilbestrol disrupts T-cell differentiation by regulating Fas/Fas ligand expression through estrogen receptor element and nuclear factor-κB motifs.

Authors:  Narendra P Singh; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2012-08-10       Impact factor: 4.030

Review 3.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

Review 4.  Sex and inflammation in respiratory diseases: a clinical viewpoint.

Authors:  Georges J Casimir; Nicolas Lefèvre; Francis Corazza; Jean Duchateau
Journal:  Biol Sex Differ       Date:  2013-09-01       Impact factor: 5.027

Review 5.  Estrogen signaling in metabolic inflammation.

Authors:  Rosário Monteiro; Diana Teixeira; Conceição Calhau
Journal:  Mediators Inflamm       Date:  2014-10-23       Impact factor: 4.711

6.  Tumor necrosis factor alfa and interleukin 1 alfa induced phosphorylation and degradation of inhibitory kappa B alpha are regulated by estradiol in endometrial cells.

Authors:  Sefa Arlıer; Ümit Ali Kayışlı; Aydın Arıcı
Journal:  Turk J Obstet Gynecol       Date:  2018-03-29

Review 7.  An Update on the Multifaceted Role of NF-kappaB in Endometriosis.

Authors:  Yuanmeng Liu; Jianzhang Wang; Xinmei Zhang
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

8.  An additive interaction between the NFkappaB and estrogen receptor signalling pathways in human endometrial epithelial cells.

Authors:  A E King; F Collins; T Klonisch; J-M Sallenave; H O D Critchley; P T K Saunders
Journal:  Hum Reprod       Date:  2009-12-02       Impact factor: 6.918

Review 9.  Estrogen-related mechanisms in sex differences of hypertension and target organ damage.

Authors:  Andrea Rodrigues Sabbatini; Georgios Kararigas
Journal:  Biol Sex Differ       Date:  2020-06-01       Impact factor: 5.027

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.